HartmannWillner invites you to subscribe to our monthly newsletter. Each month we will offer original content relevant to the work in your field.
- FDA Releases Draft Guidance on Statistical Approaches to Evaluate Analytical Similarity Between Biosimilars
- HW reports advice from FDA, CDER reviewers
- FDA released a guidance on interchangeability earlier this year, is your company ready?
- The FDA and Scientific Experts Discuss Infectious Disease Risk
- Subscribe to the HartmannWillner Newsletter